The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
about
Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.BMI1, a new target of CK2αSilencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.Biliary tract cancer stem cells - translational options and challenges.EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells.Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma.The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains.Update on the role and therapeutic potential of polycomb repressive complexes in (biliary tract) cancer.Miniaturization of the Clonogenic Assay Using Confluence Measurement.Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer.Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma.
P2860
Q33888935-A6A0D525-83FF-4A58-A851-687D2B1E4EBEQ37534719-5A9654F6-BF26-4407-9797-A65F3200EDC6Q37686453-757E3FFB-22AC-491D-B3BA-9E49E81301F0Q38713758-5597898F-F549-4B0F-A633-BEBC29F8D3FAQ38748203-5FE9B23E-4E33-4D72-ACE0-45A0DDE2BEA1Q39279276-8D10DEF8-4FB6-45F8-8177-979316721830Q39340502-5DFC9A11-AF0D-43BE-B8EF-44191DC14C68Q40330456-C877BB5F-B68B-4528-B5A4-81FB3337FA70Q46859591-99A8F833-BFB1-487B-912E-83677B1AF247Q47101382-9374E29D-31F3-4D2F-8D7F-683479B39B2AQ49923383-DD3A7EF4-B79E-49E3-9BCE-873C5AF9104AQ52671490-E8CEFE7D-CF20-4EC1-BA66-E7CF4ED26611Q54939968-FC6306DB-BF0C-4EF3-9C14-C23BE932618CQ55504502-4A252809-4803-466D-96C6-EB3A700398B6
P2860
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The BMI1 inhibitor PTC-209 is ...... in biliary tract cancer cells
@ast
The BMI1 inhibitor PTC-209 is ...... in biliary tract cancer cells
@en
The BMI1 inhibitor PTC-209 is ...... in biliary tract cancer cells
@nl
type
label
The BMI1 inhibitor PTC-209 is ...... in biliary tract cancer cells
@ast
The BMI1 inhibitor PTC-209 is ...... in biliary tract cancer cells
@en
The BMI1 inhibitor PTC-209 is ...... in biliary tract cancer cells
@nl
prefLabel
The BMI1 inhibitor PTC-209 is ...... in biliary tract cancer cells
@ast
The BMI1 inhibitor PTC-209 is ...... in biliary tract cancer cells
@en
The BMI1 inhibitor PTC-209 is ...... in biliary tract cancer cells
@nl
P2093
P2860
P356
P1433
P1476
The BMI1 inhibitor PTC-209 is ...... in biliary tract cancer cells
@en
P2093
Andrej Wagner
Christian Mayr
Daniel Neureiter
Daniela Bruckner
Frieder Berr
Magdalena Loeffelberger
Martin Jakab
Martin Pichler
Matthias Ocker
P2860
P304
P356
10.18632/ONCOTARGET.6378
P407
P577
2015-11-24T00:00:00Z